MarginsXMarginsX
Home › Markets › Industrials › SEER

Seer Inc. (SEER)

SEER trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.48
-5.73% on the day
Market cap
$82.6M
Micro cap
Revenue · 2025
$16.6M
+17.0% on 2024
Net income · 2025
-$73.6M
-444.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1726445/000119312526085481/0001193125-26-085481-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSEER on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2020
SEC CIK0001726445
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$16.6M
Net income-$73.6M
Operating income-$78.0M
Net margin-444.0%
Operating margin-470.5%
Revenue growth+17.0%
Cash$47.3M
Total assets$296.1M
P/E (computed)Net income was not positive
P/S (computed)5.0×

Warning signs

Cash runway
7.8 months
$29.3M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 10, 2026
Insider net buying, 12 months
-$194K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-10
Cash and burn$29.3M cash; operating cash flow -$11.3M a quarter.Report 2026-09-30
Shares outstanding55,814,767 (2026-11-06).Cover page 2026-11-06
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Francisco, California, United StatesPCAOB Form AP 2026-03-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $194K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$4.0M-$13.7M-$9.5M$29.3MNo debt tags$14.1M10-Q 2026-11-10
Q2 2026
2026-06-30
$3.1M-$16.9M-$9.6M$26.1MNo debt tags$14.2M10-Q 2026-08-11
Q1 2026
2026-03-31
$2.8M-$16.8M-$15.4M$47.3MNo debt tags$15.2M10-Q 2026-05-13
Q4 2025
2025-12-31
$4.2M-$16.0M-$10.8M$47.3MNo debt tags$16.6M10-K 2026-03-02
Q3 2025
2025-09-30
$4.1M-$18.2M-$7.6M$45.0MNo debt tags$16.4M10-Q 2026-11-10
Q2 2025
2025-06-30
$4.1M-$19.4M-$14.7M$37.9MNo debt tags$16.3M10-Q 2026-08-11
Q1 2025
2025-03-31
$4.2M-$19.9M-$11.4M$52.4MNo debt tags$15.3M10-Q 2026-05-13
Q4 2024
2024-12-31
$4.0M-$21.7M-$11.5M$40.8MNo debt tags$14.2M10-K 2026-03-02

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42021-01-29
Latest annual report10-K/A2026-04-30
Latest quarterly / interim10-Q2026-11-10
Latest current report8-K2026-11-10
Latest proxyDEFA14A2026-07-22

Source: SEC EDGAR submissions feed, 402 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.7%
1 month-25.6%
3 months-25.2%
Year to date-14.2%
1 year-23.0%
From 52-week high-32.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
QTRXQuanterix Corporation$2.84-3.07%$134.8M
HBIOHarvard Bioscience Inc.$8.91-5.96%$40.7M
RPIDRapid Micro Biosystems Inc.$0.7400+13.67%$37.1M
PRPOPrecipio Inc.$19.96-9.81%$35.8M
EYPTEyePoint Inc.$0.3076+0.52%$35.0M
LABStandard BioTools Inc.$0.6210-12.21%$245.2M
NAUTNautilus Biotechnology Inc.$2.10-9.48%$267.5M
CIRCCircle8 Group Inc.$0.1702-7.30%$20.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier